James Murray (@jamesmurray07) 's Twitter Profile
James Murray

@jamesmurray07

Respiratory doctor, related to some people, passionate about little. Lurker

ID: 1415205289

calendar_today09-05-2013 10:35:34

1,1K Tweet

335 Followers

493 Following

Garth Nicholas (@garth_nicholas1) 's Twitter Profile Photo

November 14: Controversy, hierarchy For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/17

November 14:  Controversy, hierarchy 
For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/17
Garth Nicholas (@garth_nicholas1) 's Twitter Profile Photo

16 November: The right side of the curve For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/14

16 November: The right side of the curve

For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/14
Garth Nicholas (@garth_nicholas1) 's Twitter Profile Photo

18 November: Pemetrexed & placebo For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/13

18 November: Pemetrexed & placebo

For Lung Cancer Awareness Month #LCAM I’m going to summarize 30 important lung cancer trials over 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial. #lcsm 1/13
Garth Nicholas (@garth_nicholas1) 's Twitter Profile Photo

19 Nov: Ipi-nivo-meso, stratified randomization For Lung Cancer Awareness Month #LCAM I’m going to review 30 important lung cancer trials in 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/18

19 Nov: Ipi-nivo-meso, stratified randomization

For Lung Cancer Awareness Month #LCAM I’m going to review 30 important lung cancer trials in 30 days. These posts are directed at non-medical professionals, with descriptions of the results and of what makes a good trial.#lcsm 1/18
Krishnan Guru-Murthy (@krishgm) 's Twitter Profile Photo

Watch this it’s fascinating - I asked James Timpson what he’d do about prisons and sentencing if he was in charge. He believes only a third of prisoners in jail should definitely be there. He’s now in charge of prisons (but not sentencing).

Ian Fraser (@ian_fraser) 's Twitter Profile Photo

James Dyson sued the Daily Mirror over an article describing him as “the vacuum-cleaner tycoon who championed Vote Leave due to the economic opportunities it would bring to British industry before moving his global head office to Singapore.” He lost. bbc.co.uk/news/uk-englan…

Uriel Suárez (@usuarezmd) 's Twitter Profile Photo

“We suggest not to taper glucocorticoids in patients on short-term glucocorticoid therapy of <3-4 weeks, irrespective of the dose. In these cases, glucocorticoids can be stopped without testing due to low concern for HPA axis suppression.” 👇🏻 academic.oup.com/ejendo/article…

Love Your Lungs (@kingsresp) 's Twitter Profile Photo

A day late but no less fun. it's this week's #ThoracicThursday #SCE style quiz question! Get your answers in quick. Explanation on Sunday. #RespEd

A day late but no less fun. it's this week's #ThoracicThursday #SCE style quiz question! Get your answers in quick. Explanation on Sunday. #RespEd
Love Your Lungs (@kingsresp) 's Twitter Profile Photo

Good morning! It's time for our regular #ThoracicThursday #SCE style quiz questions, & this week we're thinking about #lungcancer treatments. Share with colleagues, & get your answer in before explanations at the weekend. #RespEd #RespIsBest

Good morning! It's time for our regular #ThoracicThursday #SCE style quiz questions, &amp; this week we're thinking about #lungcancer treatments.  Share with colleagues, &amp; get your answer in before explanations at the weekend. #RespEd #RespIsBest
The Lancet (@thelancet) 's Twitter Profile Photo

Targeted therapies have radically improved treatment for advanced non-small-cell lung cancer (NSCLC), but challenges still remain. A Review discusses the promise and challenges of therapeutic advancements in advanced NSCLC: hubs.li/Q02M07Vp0

Targeted therapies have radically improved treatment for advanced non-small-cell lung cancer (NSCLC), but challenges still remain.

A Review discusses the promise and challenges of therapeutic advancements in advanced NSCLC: hubs.li/Q02M07Vp0
ERS publications (@erspublications) 's Twitter Profile Photo

Breathe: Chest radiography, CT scan and PET-CT are required for staging NSCLC. Stage IA tumours should be resected. Stereotactic body radiotherapy may be used if surgery is not possible. Stage IB to IIB disease require multimodality approaches. bit.ly/3RVbQMu

Love Your Lungs (@kingsresp) 's Twitter Profile Photo

Answers coming very soon! Have you read the latest British Thoracic Society (BTS) guidance on pleural disease? It might help you with this question! #RespEd #RespIsBest #pleural

Jacob de Wolff 🇳🇱🚲☕️ (@jfdwolff) 's Twitter Profile Photo

Parul Kalia SAM Online The study shows why. We need to do ~100 LPs to catch one positive xanthochromia. Older studies on which the current guidelines are based were performed with 1990s CT scanners...

UKLCC (@uklungcancer) 's Twitter Profile Photo

We've written to NHS England Genomics England Wes Streeting regarding the need to reduce genomic testing turnaround times for lung cancer and asked them to publish what recent progress has been made. Read the letter 📄ow.ly/oZ6S50TXihk #LungCancerAwarenessMonth

We've written to <a href="/NHSEngland/">NHS England</a> <a href="/GenomicsEngland/">Genomics England</a> <a href="/wesstreeting/">Wes Streeting</a> regarding the need to reduce genomic testing turnaround times for lung cancer and asked them to publish what recent progress has been made.

Read the letter 📄ow.ly/oZ6S50TXihk

#LungCancerAwarenessMonth